DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY
Clinical trials for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY explained in plain language.
Never miss a new study
Get alerted when new DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY trials appear
Sign up with your email to follow new studies for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a urea cycle drug help kids with rare epilepsy?
Disease control OngoingThis early-phase trial is testing whether glycerol phenylbutyrate (Ravicti), a drug already approved for a different condition, is safe and tolerable for children with genetic disorders like STXBP1 and SLC6A1 that cause seizures and developmental delays. The study will enroll 50 …
Matched conditions: DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY
Phase: EARLY_PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug LP352 aims to control seizures in severe epilepsy over the long term
Disease control ENROLLING_BY_INVITATIONThis phase 3 study is testing the long-term safety and effectiveness of LP352 (Bexicaserin) in 324 children and adults with developmental and epileptic encephalopathy (DEE), including Dravet and Lennox-Gastaut syndromes. Participants who completed earlier studies will receive LP3…
Matched conditions: DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY
Phase: PHASE3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC